Insider Trading activities at Deciphera Pharmaceuticals, Inc. (DCPH)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Deciphera Pharmaceuticals, Inc. (DCPH) since 2017 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Deciphera Pharmaceuticals, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1654151.

Total stock buying since 2017: $57,692,184.
Total stock sales since 2017: $103,451,582.
Total stock option exercises since 2017: $5,570,827.

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at *Deciphera Pharmaceuticals, Inc.* (*DCPH*).
	Insider Buying		Insider Sales		Option Exercises
Year	Shares	Value	Shares	Value	Shares	Value
2024	0	$0	18,277	$276,129	0	$0
2023	1,677,666	$30,152,404	100,821	$1,406,033	0	$0
2022	1,478,978	$14,789,780	13,923	$139,453	0	$0
2021	0	$0	76,523	$3,675,110	73,778	$217,726
2020	0	$0	796,582	$43,946,411	983,608	$3,541,806
2019	0	$0	1,298,450	$54,008,446	913,921	$1,811,295
2017	750,000	$12,750,000	0	$0	0	$0

Table 2. Monthly summary of insider trading at *Deciphera Pharmaceuticals, Inc.* (*DCPH*).
Trading Period	Insider Buying		Insider Sales		Option Exercises
year-month	Shares	Value	Shares	Value	Shares	Value
2024-02	0	$0	10,159	$158,663	0	$0
2024-01	0	$0	8,118	$117,466	0	$0
2023-11	0	$0	17,801	$223,758	0	$0
2023-10	0	$0	32,005	$386,581	0	$0
2023-06	0	$0	7,441	$107,163	0	$0
2023-05	11,000	$152,416	0	$0	0	$0
2023-03	0	$0	7,500	$116,782	0	$0
2023-02	0	$0	36,074	$571,749	0	$0
2023-01	1,666,666	$29,999,988	0	$0	0	$0
2022-06	0	$0	7,913	$85,064	0	$0
2022-04	1,478,978	$14,789,780	0	$0	0	$0
2022-02	0	$0	6,010	$54,389	0	$0
2021-10	0	$0	2,659	$88,199	0	$0
2021-05	0	$0	8,000	$371,272	8,000	$23,360
2021-04	0	$0	22,700	$1,011,136	22,700	$73,185
2021-03	0	$0	8,000	$354,456	8,000	$15,120
2021-02	0	$0	9,164	$419,386	8,000	$15,120
2021-01	0	$0	26,000	$1,430,661	27,078	$90,941
2020-12	0	$0	19,000	$1,169,469	19,207	$43,037
2020-11	0	$0	38,315	$2,322,093	41,012	$165,272
2020-10	0	$0	148,541	$7,750,001	148,541	$280,742
2020-09	0	$0	12,000	$566,109	12,000	$22,680
2020-08	0	$0	0	$0	9,216	$21,813
2020-07	0	$0	148,541	$8,527,051	278,729	$531,216

Table 3. Detailed insider trading at *Deciphera Pharmaceuticals, Inc.* (*DCPH*)
Trade Date	Insider Name	Trade Type	Shares	Price ($)	Value ($)
2024-02-16	Pitman Jama (SVP, Chief Development Officer)	Sale	2,267	15.62	35,406
2024-02-16	Martin Daniel C. (Chief Commercial Officer)	Sale	2,267	15.62	35,406
2024-02-16	Kelly Thomas Patrick (Chief Financial Officer)	Sale	3,010	15.62	47,010
2024-02-16	Sherman Matthew L (EVP & Chief Medical Officer)	Sale	2,615	15.62	40,841
2024-01-16	Pitman Jama (SVP, Chief Development Officer)	Sale	1,624	14.47	23,499
2024-01-16	Martin Daniel C. (Chief Commercial Officer)	Sale	1,624	14.47	23,499
2024-01-16	Kelly Thomas Patrick (Chief Financial Officer)	Sale	2,435	14.47	35,234
2024-01-16	Sherman Matthew L (EVP & Chief Medical Officer)	Sale	2,435	14.47	35,234
2023-11-30	Martin Daniel C. (Chief Commercial Officer)	Sale	17,801	12.57	223,758
2023-10-30	Pitman Jama (See Remarks)	Sale	1,407	12.02	16,909
2023-10-30	Martin Daniel C. (Chief Commercial Officer)	Sale	1,407	12.02	16,909
2023-10-30	Hoerter Steven L. (President and CEO)	Sale	21,573	12.02	259,264
2023-10-30	Kelly Thomas Patrick (Chief Financial Officer)	Sale	2,316	12.02	27,833
2023-10-30	Sherman Matthew L (EVP & Chief Medical Officer)	Sale	2,360	12.02	28,362
2023-10-02	Sherman Matthew L (EVP & Chief Medical Officer)	Sale	2,942	12.68	37,304
2023-06-16	Pitman Jama (See Remarks)	Sale	1,238	14.40	17,829
2023-06-16	Martin Daniel C. (Chief Commercial Officer)	Sale	1,238	14.40	17,829
2023-06-16	Flynn Daniel Lee (Chief Scientific Officer)	Sale	1,655	14.40	23,835
2023-06-16	Kelly Thomas Patrick (Chief Financial Officer)	Sale	1,655	14.40	23,835
2023-06-16	Sherman Matthew L (EVP & Chief Medical Officer)	Sale	1,655	14.40	23,835
2023-05-10	Walsh Dennis Leo (Director)	Buy	11,000	13.86	152,416
2023-03-21	Hoerter Steven L. (President and CEO)	Sale	7,500	15.57	116,782
2023-02-16	Pitman Jama (See Remarks)	Sale	1,159	15.10	17,499
2023-02-16	Martin Daniel C. (Chief Commercial Officer)	Sale	1,159	15.10	17,499
2023-02-16	Flynn Daniel Lee (Chief Scientific Officer)	Sale	1,370	15.10	20,685
2023-02-16	Kelly Thomas Patrick (Chief Financial Officer)	Sale	1,370	15.10	20,685
2023-02-16	Sherman Matthew L (EVP & Chief Medical Officer)	Sale	971	15.10	14,661
2023-02-14	Hoerter Steven L. (President and CEO)	Sale	30,045	16.00	480,720
2023-01-24	Brightstar Associates Llc (10% Owner)	Buy	1,666,666	18.00	29,999,988
2022-06-16	Pitman Jama (See Remarks)	Sale	1,298	10.75	13,953
2022-06-16	Martin Daniel C. (Chief Commercial Officer)	Sale	1,311	10.75	14,093
2022-06-16	Flynn Daniel Lee (Chief Scientific Officer)	Sale	1,768	10.75	19,006
2022-06-16	Kelly Thomas Patrick (Chief Financial Officer)	Sale	1,768	10.75	19,006
2022-06-16	Sherman Matthew L (EVP & Chief Medical Officer)	Sale	1,768	10.75	19,006
2022-04-29	Brightstar Associates Llc (10% Owner)	Buy	1,478,978	10.00	14,789,780
2022-02-16	Pitman Jama (See Remarks)	Sale	1,146	9.05	10,371
2022-02-16	Martin Daniel C. (Chief Commercial Officer)	Sale	1,146	9.05	10,371
2022-02-16	Flynn Daniel Lee (Chief Scientific Officer)	Sale	1,366	9.05	12,362
2022-02-16	Kelly Thomas Patrick (Chief Financial Officer)	Sale	1,368	9.05	12,380
2022-02-16	Sherman Matthew L (EVP & Chief Medical Officer)	Sale	984	9.05	8,905
2021-10-04	Sherman Matthew L (EVP & Chief Medical Officer)	Sale	2,659	33.17	88,199
2021-05-03	Taylor Michael Douglas (Director)	Sale	8,000	46.41	371,272
2021-05-03	Taylor Michael Douglas (Director)	Option Ex	8,000	2.92	23,360
2021-04-12	Bristol James Arthur (Director)	Sale	14,700	43.90	645,256
2021-04-12	Bristol James Arthur (Director)	Option Ex	14,700	3.95	58,065
2021-04-01	Taylor Michael Douglas (Director)	Sale	8,000	45.73	365,880
2021-04-01	Taylor Michael Douglas (Director)	Option Ex	8,000	1.89	15,120
2021-03-01	Taylor Michael Douglas (Director)	Sale	8,000	44.31	354,456
2021-03-01	Taylor Michael Douglas (Director)	Option Ex	8,000	1.89	15,120
2021-02-16	Flynn Daniel Lee (Chief Scientific Officer)	Sale	508	48.87	24,825
2021-02-16	Kelly Thomas Patrick (Chief Financial Officer)	Sale	524	48.87	25,607
2021-02-16	Sherman Matthew L (EVP & Chief Medical Officer)	Sale	132	48.87	6,450
2021-02-01	Taylor Michael Douglas (Director)	Sale	8,000	45.31	362,504
2021-02-01	Taylor Michael Douglas (Director)	Option Ex	8,000	1.89	15,120
2021-01-21	Hoerter Steven L. (President and CEO)	Option Ex	1,078	25.40	27,381
2021-01-15	Bristol James Arthur (Director)	Sale	7,000	50.66	354,634
2021-01-15	Bristol James Arthur (Director)	Option Ex	7,000	3.95	27,650
2021-01-04	Taylor Michael Douglas (Director)	Sale	19,000	56.63	1,076,027
2021-01-04	Taylor Michael Douglas (Director)	Option Ex	19,000	1.89	35,910
2020-12-09	Sherman Matthew L (EVP & Chief Medical Officer)	Option Ex	207	34.43	7,127
2020-12-01	Taylor Michael Douglas (Director)	Sale	19,000	61.55	1,169,469
2020-12-01	Taylor Michael Douglas (Director)	Option Ex	19,000	1.89	35,910
2020-11-16	Sherman Matthew L (EVP & Chief Medical Officer)	Option Ex	2,697	34.43	92,857
2020-11-04	Taylor Michael Douglas (Director)	Sale	15,000	65.01	975,209
2020-11-04	Taylor Michael Douglas (Director)	Option Ex	15,000	1.89	28,350
2020-11-02	Taylor Michael Douglas (Director)	Sale	23,315	57.77	1,346,884
2020-11-02	Taylor Michael Douglas (Director)	Option Ex	23,315	1.89	44,065
2020-10-09	Bristol James Arthur (Director)	Sale	23,541	54.44	1,281,501
2020-10-09	Bristol James Arthur (Director)	Option Ex	23,541	1.89	44,492
2020-10-01	Taylor Michael Douglas (Director)	Sale	125,000	51.75	6,468,500
2020-10-01	Taylor Michael Douglas (Director)	Option Ex	125,000	1.89	236,250
2020-09-14	Kelly Thomas Patrick (Chief Financial Officer)	Sale	3,000	50.01	150,036
2020-09-14	Kelly Thomas Patrick (Chief Financial Officer)	Option Ex	3,000	1.89	5,670
2020-09-10	Kelly Thomas Patrick (Chief Financial Officer)	Sale	3,000	47.71	143,127
2020-09-10	Kelly Thomas Patrick (Chief Financial Officer)	Option Ex	3,000	1.89	5,670
2020-09-08	Kelly Thomas Patrick (Chief Financial Officer)	Sale	6,000	45.49	272,946
2020-09-08	Kelly Thomas Patrick (Chief Financial Officer)	Option Ex	6,000	1.89	11,340
2020-08-20	Hoerter Steven L. (President and CEO)	Option Ex	187	25.40	4,749
2020-08-10	Flynn Daniel Lee (Chief Scientific Officer)	Option Ex	9,029	1.89	17,064
2020-07-22	Flynn Daniel Lee (Chief Scientific Officer)	Option Ex	130,000	1.89	245,700
2020-07-20	Hoerter Steven L. (President and CEO)	Option Ex	188	25.40	4,775
2020-07-09	Bristol James Arthur (Director)	Sale	23,541	55.76	1,312,740
2020-07-09	Bristol James Arthur (Director)	Option Ex	23,541	1.89	44,492
2020-07-06	Taylor Michael Douglas (Director)	Sale	27,544	55.97	1,541,747
2020-07-06	Taylor Michael Douglas (Director)	Option Ex	27,544	1.89	52,058
2020-07-02	Taylor Michael Douglas (Director)	Sale	48,245	56.94	2,747,118
2020-07-02	Taylor Michael Douglas (Director)	Option Ex	48,245	1.89	91,183
2020-07-01	Taylor Michael Douglas (Director)	Sale	49,211	59.45	2,925,446
2020-07-01	Taylor Michael Douglas (Director)	Option Ex	49,211	1.89	93,008
2020-06-18	Hoerter Steven L. (President and CEO)	Option Ex	187	25.40	4,749
2020-06-05	Allen Patricia L (Director)	Sale	5,635	55.90	314,996
2020-06-05	Allen Patricia L (Director)	Option Ex	5,635	25.73	144,988
2020-06-03	Allen Patricia L (Director)	Sale	6,365	59.14	376,451
2020-06-03	Allen Patricia L (Director)	Option Ex	6,365	25.73	163,771
2020-05-28	Hoerter Steven L. (President and CEO)	Option Ex	188	25.40	4,775
2020-05-11	Kelly Thomas Patrick (Chief Financial Officer)	Sale	12,000	55.32	663,840
2020-05-11	Kelly Thomas Patrick (Chief Financial Officer)	Option Ex	12,000	1.89	22,680
2020-04-28	Taylor Michael Douglas (Director)	Sale	25,000	56.60	1,414,975
2020-04-28	Taylor Michael Douglas (Director)	Option Ex	25,000	1.89	47,250
2020-04-21	Hoerter Steven L. (President and CEO)	Option Ex	187	25.40	4,749
2020-04-17	Taylor Michael Douglas (Director)	Sale	23,892	46.67	1,115,159
2020-04-17	Taylor Michael Douglas (Director)	Option Ex	23,892	1.89	45,155
2020-04-14	Taylor Michael Douglas (Director)	Sale	1,108	46.71	51,752
2020-04-14	Taylor Michael Douglas (Director)	Option Ex	1,108	1.89	2,094
2020-04-09	Bristol James Arthur (Director)	Sale	23,542	44.24	1,041,498
2020-04-09	Bristol James Arthur (Director)	Option Ex	23,542	1.89	44,494
2020-04-01	Taylor Michael Douglas (Director)	Sale	75,000	38.70	2,902,350
2020-04-01	Taylor Michael Douglas (Director)	Option Ex	75,000	1.89	141,750
2020-03-18	Hoerter Steven L. (President and CEO)	Option Ex	2,250	25.40	57,150
2020-01-24	Allen Patricia L (Director)	Sale	25,000	66.61	1,665,350
2020-01-22	Martin Daniel C. (Chief Commercial Officer)	Sale	26,999	67.18	1,813,711
2020-01-22	Martin Daniel C. (Chief Commercial Officer)	Option Ex	26,999	36.10	974,663
2020-01-16	Morl Christopher John (Chief Business Officer)	Sale	3,011	65.40	196,931
2020-01-16	Morl Christopher John (Chief Business Officer)	Option Ex	3,011	3.95	11,893
2020-01-16	Flynn Daniel Lee (Chief Scientific Officer)	Option Ex	66,906	5.04	337,206
2020-01-15	Morl Christopher John (Chief Business Officer)	Sale	12,023	65.23	784,272
2020-01-15	Morl Christopher John (Chief Business Officer)	Option Ex	12,023	3.95	47,490
2020-01-08	Morl Christopher John (Chief Business Officer)	Sale	12,281	60.12	738,272
2020-01-08	Morl Christopher John (Chief Business Officer)	Option Ex	12,281	3.95	48,509
2020-01-07	Morl Christopher John (Chief Business Officer)	Sale	1,650	60.02	99,036
2020-01-07	Morl Christopher John (Chief Business Officer)	Option Ex	1,650	3.95	6,517
2020-01-03	Bristol James Arthur (Director)	Sale	7,989	57.52	459,495
2020-01-03	Bristol James Arthur (Director)	Option Ex	7,989	1.89	15,099
2020-01-03	Taylor Michael Douglas (Director)	Sale	31,422	57.49	1,806,607
2020-01-03	Taylor Michael Douglas (Director)	Option Ex	31,422	1.89	59,387
2020-01-03	Kelly Thomas Patrick (Chief Financial Officer)	Sale	4,359	57.59	251,039
2020-01-03	Kelly Thomas Patrick (Chief Financial Officer)	Option Ex	4,359	1.89	8,238
2020-01-02	Morl Christopher John (Chief Business Officer)	Sale	16,137	60.00	968,268
2020-01-02	Morl Christopher John (Chief Business Officer)	Option Ex	16,137	3.95	63,741
2020-01-02	Bristol James Arthur (Director)	Sale	15,553	59.21	920,908
2020-01-02	Bristol James Arthur (Director)	Option Ex	15,553	1.89	29,395
2020-01-02	Taylor Michael Douglas (Director)	Sale	93,578	59.56	5,573,224
2020-01-02	Taylor Michael Douglas (Director)	Option Ex	93,578	1.89	176,862
2020-01-02	Kelly Thomas Patrick (Chief Financial Officer)	Sale	7,641	59.36	453,554
2020-01-02	Kelly Thomas Patrick (Chief Financial Officer)	Option Ex	7,641	1.89	14,441
2019-12-23	Kelly Thomas Patrick (Chief Financial Officer)	Sale	40,000	68.21	2,728,360
2019-12-23	Kelly Thomas Patrick (Chief Financial Officer)	Option Ex	40,000	1.89	75,600
2019-12-12	Morl Christopher John (Chief Business Officer)	Sale	15,034	60.00	902,040
2019-12-12	Morl Christopher John (Chief Business Officer)	Option Ex	15,034	3.95	59,384
2019-12-12	Flynn Daniel Lee (Chief Scientific Officer)	Sale	31,029	60.00	1,861,740
2019-12-10	Morl Christopher John (Chief Business Officer)	Sale	11,647	55.00	640,585
2019-12-10	Morl Christopher John (Chief Business Officer)	Option Ex	11,647	3.95	46,005
2019-12-10	Flynn Daniel Lee (Chief Scientific Officer)	Sale	122,752	55.00	6,751,360
2019-12-10	Flynn Daniel Lee (Chief Scientific Officer)	Option Ex	122,752	1.89	232,001
2019-12-09	Morl Christopher John (Chief Business Officer)	Sale	3,387	55.00	186,285
2019-12-09	Morl Christopher John (Chief Business Officer)	Option Ex	3,387	3.95	13,378
2019-12-09	Flynn Daniel Lee (Chief Scientific Officer)	Sale	30,175	55.00	1,659,625
2019-12-09	Flynn Daniel Lee (Chief Scientific Officer)	Option Ex	30,175	1.89	57,030
2019-12-03	Morl Christopher John (Chief Business Officer)	Sale	15,034	50.00	751,760
2019-12-03	Morl Christopher John (Chief Business Officer)	Option Ex	15,034	.00	0
2019-11-11	Flynn Daniel Lee (Chief Scientific Officer)	Sale	143,185	48.01	6,874,884
2019-11-11	Flynn Daniel Lee (Chief Scientific Officer)	Option Ex	143,185	1.89	270,619
2019-11-08	Flynn Daniel Lee (Chief Scientific Officer)	Sale	9,742	48.00	467,616
2019-11-08	Flynn Daniel Lee (Chief Scientific Officer)	Option Ex	9,742	1.89	18,412
2019-11-01	Bristol James Arthur (Director)	Sale	25,000	45.07	1,126,825
2019-11-01	Bristol James Arthur (Director)	Option Ex	25,000	1.89	47,250
2019-11-01	Taylor Michael Douglas (Director)	Sale	7,500	45.02	337,642
2019-11-01	Taylor Michael Douglas (Director)	Option Ex	7,500	1.89	14,175
2019-10-28	Flynn Daniel Lee (Chief Scientific Officer)	Sale	29,820	40.00	1,192,800
2019-10-28	Flynn Daniel Lee (Chief Scientific Officer)	Option Ex	29,820	1.89	56,359
2019-10-28	Kelly Thomas Patrick (Chief Financial Officer)	Sale	3,750	40.00	150,011
2019-10-28	Kelly Thomas Patrick (Chief Financial Officer)	Option Ex	3,750	1.89	7,087
2019-09-19	Martin Daniel C. (Chief Commercial Officer)	Sale	3,000	35.56	106,689
2019-09-11	Taylor Michael Douglas (Director)	Sale	22,500	35.11	789,907
2019-09-11	Taylor Michael Douglas (Director)	Option Ex	22,500	1.89	42,525
2019-09-11	Kelly Thomas Patrick (Chief Financial Officer)	Sale	11,250	35.11	395,032
2019-09-11	Kelly Thomas Patrick (Chief Financial Officer)	Option Ex	11,250	1.89	21,262
2019-09-03	Taylor Michael Douglas (Director)	Sale	7,500	36.26	271,972
2019-09-03	Taylor Michael Douglas (Director)	Option Ex	7,500	1.89	14,175
2019-08-16	New Leaf Bpo Associates I, L.p. (10% Owner)	Sale	200,000	36.78	7,355,800
2019-08-15	New Leaf Bpo Associates I, L.p. (10% Owner)	Sale	150,000	36.09	5,413,650
2019-08-13	Bristol James Arthur (Director)	Sale	25,000	41.17	1,029,350
2019-08-13	Bristol James Arthur (Director)	Option Ex	25,000	1.89	47,250
2019-08-13	Flynn Daniel Lee (Chief Scientific Officer)	Sale	148,107	41.50	6,145,996
2019-08-13	Flynn Daniel Lee (Chief Scientific Officer)	Option Ex	123,107	1.89	232,672
2019-08-13	Taylor Michael Douglas (Director)	Sale	22,500	41.06	923,827
2019-08-13	Taylor Michael Douglas (Director)	Option Ex	22,500	1.89	42,525
2019-08-13	Kelly Thomas Patrick (Chief Financial Officer)	Sale	11,250	41.95	471,971
2019-08-13	Kelly Thomas Patrick (Chief Financial Officer)	Option Ex	11,250	1.89	21,262
2019-06-19	Kelly Thomas Patrick (Chief Financial Officer)	Sale	177	25.00	4,425
2019-06-19	Kelly Thomas Patrick (Chief Financial Officer)	Option Ex	177	1.89	334
2019-06-03	Kelly Thomas Patrick (Chief Financial Officer)	Sale	2,100	25.20	52,926
2019-06-03	Kelly Thomas Patrick (Chief Financial Officer)	Option Ex	2,100	1.89	3,969
2019-05-22	Kelly Thomas Patrick (Chief Financial Officer)	Sale	100	25.00	2,500
2019-05-22	Kelly Thomas Patrick (Chief Financial Officer)	Option Ex	100	1.89	189
2019-05-21	Kelly Thomas Patrick (Chief Financial Officer)	Sale	1,373	25.07	34,418
2019-05-21	Kelly Thomas Patrick (Chief Financial Officer)	Option Ex	1,373	1.89	2,594
2019-05-01	Kelly Thomas Patrick (Chief Financial Officer)	Sale	13,500	22.93	309,528
2019-05-01	Kelly Thomas Patrick (Chief Financial Officer)	Option Ex	13,500	1.89	25,515
2019-02-21	Flynn Daniel Lee (Chief Scientific Officer)	Option Ex	24,500	3.95	96,775
2019-02-19	Taylor Michael Douglas (President and CEO)	Sale	3,997	30.00	119,913
2019-02-19	Taylor Michael Douglas (President and CEO)	Option Ex	3,997	1.89	7,554
2019-02-19	Kelly Thomas Patrick (Chief Financial Officer)	Sale	1,500	30.00	45,000
2019-02-19	Kelly Thomas Patrick (Chief Financial Officer)	Option Ex	1,500	1.89	2,835
2019-02-15	Bristol James Arthur (Director)	Sale	17,782	28.04	498,607
2019-02-15	Bristol James Arthur (Director)	Option Ex	17,782	1.89	33,607
2019-02-15	Taylor Michael Douglas (President and CEO)	Sale	4,934	28.01	138,191
2019-02-15	Taylor Michael Douglas (President and CEO)	Option Ex	4,934	1.89	9,325
2019-02-14	Bristol James Arthur (Director)	Sale	1,101	28.01	30,842
2019-02-14	Bristol James Arthur (Director)	Option Ex	1,101	1.89	2,080
2019-02-14	Taylor Michael Douglas (President and CEO)	Sale	500	28.00	14,000
2019-02-14	Taylor Michael Douglas (President and CEO)	Option Ex	500	1.89	945
2019-02-05	Bristol James Arthur (Director)	Sale	2,595	28.02	72,704
2019-02-05	Bristol James Arthur (Director)	Option Ex	2,595	1.89	4,904
2019-02-05	Taylor Michael Douglas (President and CEO)	Sale	1,700	28.01	47,611
2019-02-05	Taylor Michael Douglas (President and CEO)	Option Ex	1,700	1.89	3,213
2019-01-16	Flynn Daniel Lee (Chief Scientific Officer)	Sale	152,629	26.00	3,968,354
2019-01-16	Flynn Daniel Lee (Chief Scientific Officer)	Option Ex	152,629	1.89	288,468
2019-01-11	Flynn Daniel Lee (Chief Scientific Officer)	Sale	300	26.00	7,800
2019-01-11	Flynn Daniel Lee (Chief Scientific Officer)	Option Ex	300	1.89	567
2019-01-07	Kelly Thomas Patrick (Chief Financial Officer)	Sale	5,000	25.18	125,900
2019-01-07	Kelly Thomas Patrick (Chief Financial Officer)	Option Ex	5,000	1.89	9,450
2017-10-02	New Leaf Bpo Associates I, L.p. (10% Owner)	Buy	375,000	17.00	6,375,000
2017-10-02	Ratcliffe Liam (Director)	Buy	375,000	17.00	6,375,000

Insider trading activities including stock purchases, stock sales, and option exercises of DCPH listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Deciphera Pharmaceuticals, Inc. (symbol DCPH, CIK number 1654151) see the Securities and Exchange Commission (SEC) website.

▪ Real-time Insider Trading

▪ Insider Officer Cluster Trading

▪ Top Officer Buys of the Week

▪ Top Officer Buys of the Month